Skip to main content
    V

    Viemed Healthcare Inc (VMD)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $9.15
    -0.02 (-0.22%)

    Market Cap: $347.48M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Viemed Healthcare Inc (VMD) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    Viemed Healthcare reported revenue of $270.28M for the fiscal year ended Dec 31, 2025, up 20.5% from the year before. That year, net income was $15.38M with a net margin of 5.7%, operating cash flow was $51.92M and free cash flow was $11.93M. The quarter ended Sep 30, 2026 had revenue of $80.67M and net income of $4.74M.

    Revenue and Margins

    The operating margin was 8.5% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $31.36M, a compound annual rate of 27.0%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$270.28M+20.5%57.5%8.5%5.7%
    Dec 2024$224.26M+22.5%59.4%8.0%5.1%
    Dec 2023$183.01M+31.8%61.6%7.8%5.6%
    Dec 2022$138.83M+18.6%61.0%5.9%4.5%
    Dec 2021$117.06M-10.8%62.7%9.9%7.8%
    Dec 2020$131.31M+63.6%61.0%20.4%24.0%
    Dec 2019$80.26M+24.5%69.8%11.0%10.6%
    Dec 2018$64.46M+37.4%74.1%15.6%14.7%
    Dec 2017$46.93M+49.7%73.8%18.8%17.4%
    Dec 2016$31.36MN/A60.1%1.2%3.9%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 34.8% from the year before. In the quarter ended Sep 2026, net income rose 31.7% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$270.28M$224.26M$183.01M$138.83M$117.06M$131.31M$80.26M$64.46M$46.93M$31.36M
    Cost of revenue$114.82M$91.05M$70.22M$54.15M$43.65M$51.20M$24.25M$16.69M$12.31M$12.50M
    Gross profit$155.46M$133.20M$112.78M$84.68M$73.41M$80.11M$56.01M$47.77M$34.62M$18.86M
    Research and development$3.02M$3.07M$2.78M$2.70M$2.11M$1.08M$848.00K$0$848.00K$848.00K
    Operating income$22.95M$17.90M$14.33M$8.25M$11.58M$26.78M$8.86M$10.06M$8.82M$383.00K
    Net income$15.38M$11.41M$10.24M$6.22M$9.13M$31.53M$8.53M$9.51M$8.18M$1.23M
    EBITDA$52.04M$43.28M$36.29M$24.87M$22.89M$36.36M$15.62M$13.63M$11.37M$1.81M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$80.67M$78.10M$75.41M$76.18M$71.91M$63.06M$59.13M$60.70M$58.00M$54.97M$50.59M$50.74M
    Gross profit$46.19M$45.05M$42.83M$44.10M$41.34M$36.73M$33.28M$36.14M$34.37M$32.89M$29.80M$32.11M
    Operating income$6.96M$4.46M$4.30M$8.37M$5.64M$5.09M$3.84M$6.45M$5.63M$3.62M$2.20M$5.29M
    Net income$4.74M$2.90M$2.71M$5.82M$3.60M$3.25M$2.71M$4.42M$3.90M$1.48M$1.60M$3.48M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $12.38M by $1.12M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$199.15M$177.07M$154.90M$117.04M$117.96M$112.56M$82.60M$53.65M$37.69M$24.68M
    Current assets$48.49M$52.88M$38.37M$39.74M$47.31M$47.17M$27.81M$23.09M$17.00M$11.20M
    Cash and equivalents$13.50M$17.54M$12.84M$16.91M$28.41M$30.98M$13.36M$10.41M$5.10M$4.34M
    Total liabilities$55.63M$43.77M$41.00M$19.95M$23.14M$30.87M$38.90M$21.08M$13.95M$11.80M
    Short-term debt$1.09M$409.00K$1.07M$0$1.48M$1.84M$1.75M$0$4.38M$3.86M
    Long-term debt$11.29M$3.59M$6.00M$0$4.31M$5.80M$7.63M$0$0$0
    Shareholder equity$141.54M$131.39M$113.89M$97.09M$94.82M$81.69M$43.70M$32.57M$23.74M$12.88M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$207.63M$204.22M$197.36M$214.94M$202.36M$184.60M$178.08M$177.07M$169.53M$163.95M$154.88M$154.90M
    Total liabilities$55.65M$58.26M$51.56M$71.42M$66.86M$42.98M$41.33M$43.77M$42.73M$42.77M$38.60M$41.00M
    Cash and equivalents$9.68M$10.68M$9.76M$13.50M$11.12M$20.02M$10.16M$17.54M$11.35M$8.81M$7.31M$12.84M
    Shareholder equity$150.09M$144.03M$143.86M$141.54M$133.61M$139.73M$134.76M$131.39M$124.96M$119.37M$116.27M$113.89M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 23.0% of operating cash flow. Dividends and share repurchases together came to 114.0% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$51.92M$39.09M$45.21M$27.75M$22.49M$35.11M$19.09M$22.37M$12.02M$6.41M
    Capital expenditures$39.98M$38.77M$26.11M$23.04M$20.34M$13.04M$13.38M$6.11M$4.00M$1.67M
    Free cash flow$11.93M$318.00K$19.10M$4.71M$2.15M$22.07M$5.70M$16.25M$8.02M$4.74M
    Dividends paid$374.00K$36.00K$0$0$111.01KN/A$405.21K$0$0$0
    Share repurchases$13.22M$0$0$9.57M$0$0$1.52M$1.59MN/AN/A
    Investing cash flow-$50.17M-$30.70M-$52.11M-$23.98M-$19.75M-$8.41M-$12.81M-$5.30M-$3.57M-$936.00K
    Financing cash flow-$5.79M-$3.69M$2.83M-$15.27M-$5.32M-$9.07M-$3.33M-$11.75M-$7.69M-$4.29M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$11.49M$15.90M$8.07M$18.44M$18.37M$12.25M$2.85M$14.99M$12.74M$10.18M$1.18M$13.28M
    Capital expenditures$8.62M$8.46M$6.71M$8.74M$7.64M$8.13M$15.48M$12.83M$11.00M$8.93M$6.01M$7.95M
    Free cash flow$2.87M$7.44M$1.36M$9.70M$10.73M$4.13M-$12.63M$2.16M$1.74M$1.25M-$4.83M$5.34M
    Last 12 quarters

    Frequently Asked Questions About VMD

    What is Viemed Healthcare's annual revenue?

    Viemed Healthcare reported revenue of $270.28M for the fiscal year ended Dec 31, 2025.

    How fast is Viemed Healthcare's revenue growing?

    Revenue was up 20.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 24.9%.

    Is Viemed Healthcare profitable?

    Yes. Viemed Healthcare reported net income of $15.38M for the fiscal year ended Dec 31, 2025, with a net margin of 5.7%.

    How much free cash flow does VMD generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $51.92M minus capital expenditures of $39.98M produced free cash flow of $11.93M.

    How much debt does Viemed Healthcare have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $11.29M, short-term debt of $1.09M and cash and equivalents of $13.50M.